tiprankstipranks
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market
2796
Pharmarise Holdings Corp.
RESEARCH TOOLSreports

Pharmarise Holdings Corp. (2796) Income Statement

0 Followers

Pharmarise Holdings Corp. Income Statement

Last quarter (Q1 2025), Pharmarise Holdings Corp.'s total revenue was ¥16.75B, an increase of 9.99% from the same quarter last year. In Q1, Pharmarise Holdings Corp.'s net income was ¥-19.00M. See Pharmarise Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
May 24May 23May 22May 21May 20
Total Revenue
¥ 63.51B¥ 54.47B¥ 52.03B¥ 51.61B¥ 51.03B
Gross Profit
¥ 8.20B¥ 7.89B¥ 7.50B¥ 7.42B¥ 6.73B
Operating Expenses
¥ 7.91B¥ 6.98B¥ 6.06B¥ 5.90B¥ 5.74B
Depreciation and Amortization
¥ 1.49B¥ 1.17B¥ 1.22B¥ 1.31B¥ 1.23B
EBITDA
¥ 1.79B¥ 2.09B¥ 2.66B¥ 2.83B¥ 2.23B
Operating Income
¥ 295.00M¥ 916.00M¥ 1.44B¥ 1.52B¥ 997.00M
Other Income/Expenses
¥ -287.00M¥ -773.00M¥ -390.00M¥ -199.00M¥ -178.00M
Pretax Income
¥ 8.00M¥ 143.00M¥ 1.05B¥ 1.32B¥ 819.00M
Net Income
¥ -368.00M¥ -351.00M¥ 333.00M¥ 448.00M¥ 577.00M
Per Share Metrics
Basic EPS
¥ -32.42¥ -33.35¥ 35.42¥ 47.90¥ 61.03
Diluted EPS
¥ -32.42¥ -33.35¥ 26.86¥ 36.22¥ 46.32
Weighted Average Shares Outstanding
 11.32M 10.52M 9.40M 9.33M 9.45M
Weighted Average Shares Outstanding (Diluted)
 11.32M 10.52M 12.47M 12.40M 12.50M
Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History